New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome

The human protein kinome comprises 535 proteins that, with the exception of approximately 50 pseudokinases, control intracellular signaling networks by catalyzing the phosphorylation of multiple protein substrates. While a major research focus of the last 30 years has been cancer-associated Tyr and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2018-01, Vol.78 (1), p.15-29
Hauptverfasser: Wilson, Leah J, Linley, Adam, Hammond, Dean E, Hood, Fiona E, Coulson, Judy M, MacEwan, David J, Ross, Sarah J, Slupsky, Joseph R, Smith, Paul D, Eyers, Patrick A, Prior, Ian A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 29
container_issue 1
container_start_page 15
container_title Cancer research (Chicago, Ill.)
container_volume 78
creator Wilson, Leah J
Linley, Adam
Hammond, Dean E
Hood, Fiona E
Coulson, Judy M
MacEwan, David J
Ross, Sarah J
Slupsky, Joseph R
Smith, Paul D
Eyers, Patrick A
Prior, Ian A
description The human protein kinome comprises 535 proteins that, with the exception of approximately 50 pseudokinases, control intracellular signaling networks by catalyzing the phosphorylation of multiple protein substrates. While a major research focus of the last 30 years has been cancer-associated Tyr and Ser/Thr kinases, over 85% of the kinome has been identified to be dysregulated in at least one disease or developmental disorder. Despite this remarkable statistic, for the majority of protein kinases and pseudokinases, there are currently no inhibitors progressing toward the clinic, and in most cases, details of their physiologic and pathologic mechanisms remain at least partially obscure. By curating and annotating data from the literature and major public databases of phosphorylation sites, kinases, and disease associations, we generate an unbiased resource that highlights areas of unmet need within the kinome. We discuss strategies and challenges associated with characterizing catalytic and noncatalytic outputs in cells, and describe successes and new frontiers that will support more comprehensive cancer-targeting and therapeutic evaluation in the future. .
doi_str_mv 10.1158/0008-5472.CAN-17-2291
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1978726782</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2006888105</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-33ea92a90340a5e17616abff55d9f21917c3303973d885880bc3d9ed135b54fa3</originalsourceid><addsrcrecordid>eNpdkE1PwkAQhjdGI4j-BE0TLx4s7keX3T0SgmIkwEHOm6WdQkm7rbutH__eNiAHT5M387yTyYPQLcFDQrh8whjLkEeCDifjRUhESKkiZ6hPOJOhiCJ-jvonpoeuvN-3kRPML1GPKsojpWQfrRfwFazA-QriOvsE_xgsq6p0dWOzOuuisUkw2Zk8B7sFH2Q2mH5Xeekyuw3qHQSzpjA2WLmyhnb3ltmygGt0kZrcw81xDtD6efo-mYXz5cvrZDwPY45pHTIGRlGjMIuw4UDEiIzMJk05T1RKiSIiZgwzJVgiJZcSb2KWKEgI4xsepYYN0MPhbuXKjwZ8rYvMx5DnxkLZeE2UkIKOhKQtev8P3ZeNs-13mmI8klK2alqKH6jYld47SHXlssK4H02w7rzrzqnunOrWuyZCd97b3t3xerMpIDm1_kSzX-erfL8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2006888105</pqid></control><display><type>article</type><title>New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome</title><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Wilson, Leah J ; Linley, Adam ; Hammond, Dean E ; Hood, Fiona E ; Coulson, Judy M ; MacEwan, David J ; Ross, Sarah J ; Slupsky, Joseph R ; Smith, Paul D ; Eyers, Patrick A ; Prior, Ian A</creator><creatorcontrib>Wilson, Leah J ; Linley, Adam ; Hammond, Dean E ; Hood, Fiona E ; Coulson, Judy M ; MacEwan, David J ; Ross, Sarah J ; Slupsky, Joseph R ; Smith, Paul D ; Eyers, Patrick A ; Prior, Ian A</creatorcontrib><description>The human protein kinome comprises 535 proteins that, with the exception of approximately 50 pseudokinases, control intracellular signaling networks by catalyzing the phosphorylation of multiple protein substrates. While a major research focus of the last 30 years has been cancer-associated Tyr and Ser/Thr kinases, over 85% of the kinome has been identified to be dysregulated in at least one disease or developmental disorder. Despite this remarkable statistic, for the majority of protein kinases and pseudokinases, there are currently no inhibitors progressing toward the clinic, and in most cases, details of their physiologic and pathologic mechanisms remain at least partially obscure. By curating and annotating data from the literature and major public databases of phosphorylation sites, kinases, and disease associations, we generate an unbiased resource that highlights areas of unmet need within the kinome. We discuss strategies and challenges associated with characterizing catalytic and noncatalytic outputs in cells, and describe successes and new frontiers that will support more comprehensive cancer-targeting and therapeutic evaluation in the future. .</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-17-2291</identifier><identifier>PMID: 29254998</identifier><language>eng</language><publisher>United States: American Association for Cancer Research, Inc</publisher><subject>Cancer ; Developmental disabilities ; Intracellular signalling ; Kinases ; Phosphorylation ; Protein kinase ; Proteins</subject><ispartof>Cancer research (Chicago, Ill.), 2018-01, Vol.78 (1), p.15-29</ispartof><rights>2017 American Association for Cancer Research.</rights><rights>Copyright American Association for Cancer Research, Inc. Jan 1, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-33ea92a90340a5e17616abff55d9f21917c3303973d885880bc3d9ed135b54fa3</citedby><cites>FETCH-LOGICAL-c502t-33ea92a90340a5e17616abff55d9f21917c3303973d885880bc3d9ed135b54fa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3343,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29254998$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wilson, Leah J</creatorcontrib><creatorcontrib>Linley, Adam</creatorcontrib><creatorcontrib>Hammond, Dean E</creatorcontrib><creatorcontrib>Hood, Fiona E</creatorcontrib><creatorcontrib>Coulson, Judy M</creatorcontrib><creatorcontrib>MacEwan, David J</creatorcontrib><creatorcontrib>Ross, Sarah J</creatorcontrib><creatorcontrib>Slupsky, Joseph R</creatorcontrib><creatorcontrib>Smith, Paul D</creatorcontrib><creatorcontrib>Eyers, Patrick A</creatorcontrib><creatorcontrib>Prior, Ian A</creatorcontrib><title>New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>The human protein kinome comprises 535 proteins that, with the exception of approximately 50 pseudokinases, control intracellular signaling networks by catalyzing the phosphorylation of multiple protein substrates. While a major research focus of the last 30 years has been cancer-associated Tyr and Ser/Thr kinases, over 85% of the kinome has been identified to be dysregulated in at least one disease or developmental disorder. Despite this remarkable statistic, for the majority of protein kinases and pseudokinases, there are currently no inhibitors progressing toward the clinic, and in most cases, details of their physiologic and pathologic mechanisms remain at least partially obscure. By curating and annotating data from the literature and major public databases of phosphorylation sites, kinases, and disease associations, we generate an unbiased resource that highlights areas of unmet need within the kinome. We discuss strategies and challenges associated with characterizing catalytic and noncatalytic outputs in cells, and describe successes and new frontiers that will support more comprehensive cancer-targeting and therapeutic evaluation in the future. .</description><subject>Cancer</subject><subject>Developmental disabilities</subject><subject>Intracellular signalling</subject><subject>Kinases</subject><subject>Phosphorylation</subject><subject>Protein kinase</subject><subject>Proteins</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpdkE1PwkAQhjdGI4j-BE0TLx4s7keX3T0SgmIkwEHOm6WdQkm7rbutH__eNiAHT5M387yTyYPQLcFDQrh8whjLkEeCDifjRUhESKkiZ6hPOJOhiCJ-jvonpoeuvN-3kRPML1GPKsojpWQfrRfwFazA-QriOvsE_xgsq6p0dWOzOuuisUkw2Zk8B7sFH2Q2mH5Xeekyuw3qHQSzpjA2WLmyhnb3ltmygGt0kZrcw81xDtD6efo-mYXz5cvrZDwPY45pHTIGRlGjMIuw4UDEiIzMJk05T1RKiSIiZgwzJVgiJZcSb2KWKEgI4xsepYYN0MPhbuXKjwZ8rYvMx5DnxkLZeE2UkIKOhKQtev8P3ZeNs-13mmI8klK2alqKH6jYld47SHXlssK4H02w7rzrzqnunOrWuyZCd97b3t3xerMpIDm1_kSzX-erfL8</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Wilson, Leah J</creator><creator>Linley, Adam</creator><creator>Hammond, Dean E</creator><creator>Hood, Fiona E</creator><creator>Coulson, Judy M</creator><creator>MacEwan, David J</creator><creator>Ross, Sarah J</creator><creator>Slupsky, Joseph R</creator><creator>Smith, Paul D</creator><creator>Eyers, Patrick A</creator><creator>Prior, Ian A</creator><general>American Association for Cancer Research, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20180101</creationdate><title>New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome</title><author>Wilson, Leah J ; Linley, Adam ; Hammond, Dean E ; Hood, Fiona E ; Coulson, Judy M ; MacEwan, David J ; Ross, Sarah J ; Slupsky, Joseph R ; Smith, Paul D ; Eyers, Patrick A ; Prior, Ian A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-33ea92a90340a5e17616abff55d9f21917c3303973d885880bc3d9ed135b54fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Cancer</topic><topic>Developmental disabilities</topic><topic>Intracellular signalling</topic><topic>Kinases</topic><topic>Phosphorylation</topic><topic>Protein kinase</topic><topic>Proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wilson, Leah J</creatorcontrib><creatorcontrib>Linley, Adam</creatorcontrib><creatorcontrib>Hammond, Dean E</creatorcontrib><creatorcontrib>Hood, Fiona E</creatorcontrib><creatorcontrib>Coulson, Judy M</creatorcontrib><creatorcontrib>MacEwan, David J</creatorcontrib><creatorcontrib>Ross, Sarah J</creatorcontrib><creatorcontrib>Slupsky, Joseph R</creatorcontrib><creatorcontrib>Smith, Paul D</creatorcontrib><creatorcontrib>Eyers, Patrick A</creatorcontrib><creatorcontrib>Prior, Ian A</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wilson, Leah J</au><au>Linley, Adam</au><au>Hammond, Dean E</au><au>Hood, Fiona E</au><au>Coulson, Judy M</au><au>MacEwan, David J</au><au>Ross, Sarah J</au><au>Slupsky, Joseph R</au><au>Smith, Paul D</au><au>Eyers, Patrick A</au><au>Prior, Ian A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>78</volume><issue>1</issue><spage>15</spage><epage>29</epage><pages>15-29</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><abstract>The human protein kinome comprises 535 proteins that, with the exception of approximately 50 pseudokinases, control intracellular signaling networks by catalyzing the phosphorylation of multiple protein substrates. While a major research focus of the last 30 years has been cancer-associated Tyr and Ser/Thr kinases, over 85% of the kinome has been identified to be dysregulated in at least one disease or developmental disorder. Despite this remarkable statistic, for the majority of protein kinases and pseudokinases, there are currently no inhibitors progressing toward the clinic, and in most cases, details of their physiologic and pathologic mechanisms remain at least partially obscure. By curating and annotating data from the literature and major public databases of phosphorylation sites, kinases, and disease associations, we generate an unbiased resource that highlights areas of unmet need within the kinome. We discuss strategies and challenges associated with characterizing catalytic and noncatalytic outputs in cells, and describe successes and new frontiers that will support more comprehensive cancer-targeting and therapeutic evaluation in the future. .</abstract><cop>United States</cop><pub>American Association for Cancer Research, Inc</pub><pmid>29254998</pmid><doi>10.1158/0008-5472.CAN-17-2291</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2018-01, Vol.78 (1), p.15-29
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_1978726782
source American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals
subjects Cancer
Developmental disabilities
Intracellular signalling
Kinases
Phosphorylation
Protein kinase
Proteins
title New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T14%3A48%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20Perspectives,%20Opportunities,%20and%20Challenges%20in%20Exploring%20the%20Human%20Protein%20Kinome&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=Wilson,%20Leah%20J&rft.date=2018-01-01&rft.volume=78&rft.issue=1&rft.spage=15&rft.epage=29&rft.pages=15-29&rft.issn=0008-5472&rft.eissn=1538-7445&rft_id=info:doi/10.1158/0008-5472.CAN-17-2291&rft_dat=%3Cproquest_cross%3E2006888105%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2006888105&rft_id=info:pmid/29254998&rfr_iscdi=true